P R E S S M E M b E D D E L A N D s E 14 June 2017
Ratos held an extraordinary general meeting of Sibeliussalen, Finlandshusets konferens, Snickarbacken 4, Stockholm, sweden, 14 June 2017.
Ratos informed in a press release on 11 may 2017 to Ratos subsidiaries Sophion Holding AB has signed an agreement for the sale of all the shares in the Sophion Bioscience A/S to the Sapphire Bioscience Holding ApS, a newly formed förvärvsbolag that is controlled by the Thais Johansen, president of Sophion Bioscience A/S.
The general meeting decided today, in accordance with the board’s proposal, to approve the transfer of all shares in the Sophion Bioscience A/S to the Thais Johansen’s controlled companies.
The transfer is expected to be completed in June and does not give rise to any significant capital gain or capital loss in Ratos.
For further information:
Magnus Agervald, ceo of Ratos, 08-700 17 00
Helene Gustafsson, investor relations and press officer of Ratos, 08-700 17 98
Financial calendar from Ratos:
Interim report January-June 2017 August 17, 2017
Interim report January-september 2017 november 14, 2017
Ratos is an investment company that owns and develops unlisted medium-sized companies in the Nordic region. The goal is to as an active owner contributing to the long-term and sustainable enterprise development in the companies and to implement value-creating transactions. Ratos portfolio consists of 17 nordic medium-sized companies in which the largest sectors in the turnover are Construction, Industry and Consumer goods/Trade. Ratos is listed on Nasdaq Stockholm and has a total of approximately 14 200 employees.